Identification | More | [Name]
L(+)-Leucinol | [CAS]
7533-40-6 | [Synonyms]
2-AMINO-4-METHYL-1-PENTANOL (2S)-2-AMINO-4-METHYLPENTAN-1-OL H-LEUCINOL H-LEU-OL H-L-LEU-OL L-(+)-LEUCINOL L-LEUCINOL (S)-(+)-2-AMINO-4-METHYL-1-PENTANOL (S)-2-AMINO-4-METHYL-1-PENTANOL (S)-(+)-LEUCINOL (S)-LEUCINOL (S)-2-Amino-4-methylpentanol (S)-2-amino-4-methylpentan-1-ol L-Leu-ol (S)-2-Amino-4-methylpentanol~H-Leu-ol L-Leucinol,97% L-LEUCINOL/(S)-(+)-2-AMINO-4-METHYL-1-PENTANOL 1-PENTANOL, 2-AMINO-4-METHYL-, (2S)- (S)-(+)-LEUCINOL ((S)-(+)-2-AMINO-4-METHYL-1-PENTANOL) (S)-2-Amino-4-methyl-1-pentanol, 2-Amino-4-methyl-1-pentanol, L-Leucinol | [EINECS(EC#)]
231-400-5 | [Molecular Formula]
C6H15NO | [MDL Number]
MFCD00063676 | [Molecular Weight]
117.19 | [MOL File]
7533-40-6.mol |
Chemical Properties | Back Directory | [Appearance]
clear colorless to slightly yellow | [Melting point ]
56-58 °C | [alpha ]
3 º (589nm, c=9, ethanol) | [Boiling point ]
208-210 °C(lit.) | [density ]
0.917 g/mL at 25 °C(lit.)
| [refractive index ]
n20/D 1.4511(lit.)
| [Fp ]
195 °F
| [storage temp. ]
Store at 0°C | [form ]
Liquid | [pka]
12.88±0.10(Predicted) | [color ]
Clear colorless to slightly yellow light | [Specific Gravity]
0.917 | [optical activity]
[α]20/D +4°, c = 9 in ethanol | [Sensitive ]
Air Sensitive | [BRN ]
1719240 | [CAS DataBase Reference]
7533-40-6(CAS DataBase Reference) | [NIST Chemistry Reference]
1-Pentanol, 2-amino-4-methyl-, (S)-(7533-40-6) |
Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36:Wear suitable protective clothing . S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . S27:Take off immediately all contaminated clothing . | [WGK Germany ]
3
| [F ]
2-10 | [HS Code ]
29221990 |
Hazard Information | Back Directory | [Chemical Properties]
clear colorless to slightly yellow | [Uses]
Starting material for the synthesis of aminopeptidase N and phospholipase A2 inhibitors. |
|
|